What is DAIZ?
DAIZ is a global developer and producer of plant-based protein, distinguished by its patented Ochiai Germination Method (OGM). This breakthrough technology, refined over 25 years of plant science research, enables the custom design of highly nutritional raw materials from soybeans and other plant seeds. DAIZ's flagship product, "Miracle Meat," can be tailored to mimic the taste and texture of various meats without additives, finding application in major food manufacturers' products worldwide. Beyond food innovation, DAIZ is exploring the application of OGM in drug discovery, integrating AI to identify novel organic molecules for therapeutic research.
How much funding has DAIZ raised?
DAIZ has raised a total of $47M across 1 funding round:
Series C
$47M
Series C (2023): $47M with participation from Mitsubishi UFJ Capital, Miyoshi Oil & Fat, Roquette Frères, and The Kagoshima Bank
Key Investors in DAIZ
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital, established in 2005, offers deep expertise and access for overseas companies and investors targeting the Japanese market, having financed over 1,000 companies.
Miyoshi Oil & Fat
Miyoshi Oil & Fat is a manufacturer of oil-based raw materials for food and oil chemistry, contributing to people, society, and the future with products like margarine and shortening, and high-grade fatty acids for pharmaceuticals and cosmetics.
Roquette Frères
Roquette is a global provider of plant-based ingredients and pharmaceutical solutions, serving the food, health, and bio-based industries with high-performance solutions derived from natural raw materials.
What's next for DAIZ?
The substantial enterprise-level funding DAIZ has attracted signals a strong market validation and provides the necessary capital for scaling its innovative food technology and expanding its drug discovery initiatives. This strategic investment is expected to accelerate product development, enhance manufacturing capabilities, and broaden market reach for its plant-based protein solutions. The company's dual focus on sustainable food alternatives and cutting-edge pharmaceutical research positions it for significant growth and impact in both sectors.
See full DAIZ company page
